
翰尔西
翰尔西
Biotech/Healthcare
Hanerxi is a developer of pen injectors focused on new drug delivery methods. It has successfully developed China's first adjustable precision-dose injection pen with a complete intellectual property portfolio and has built a technology reserve covering drugs with various physical characteristics.
Latest round: Pre Series A (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.